067080 — Dae Hwa Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Dae Hwa Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,302	4,722	5,838	2,763	2,802
Net Total Accounts Receivable
Net Total Receivables	18,236	19,451	24,536	21,423	20,275
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	56,139	51,213	65,220	61,607	62,359
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	68,245	89,857	94,351	91,702	88,847
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	177,376	199,056	219,163	205,884	210,863
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	75,335	83,260	127,948	117,693	121,484
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	97,702	121,064	145,931	133,885	136,791
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	79,674	77,993	73,232	71,999	74,073
Total Liabilities & Shareholders' Equity	177,376	199,056	219,163	205,884	210,863
Total Common Shares Outstanding